Chan-Kyung Jane Cho, MD, PhD
Locations of Practice
1959 NE Pacific Street
Seattle, WA 98195
Dr. Cho has a great interest in advanced treatment options and optimization of patient experience in radiation oncology. Her fellowship focuses on stereotactic body radiotherapy and advanced imaging for the central nervous system, lung, and gastrointestinal cancers. Dr. Cho practices at UWMC, Harborview Medical Center and SCCA Proton Therapy Center.
Patient Care Philosophy
“Together with the best available medical evidence, understanding the unique goals and circumstances of each patient truly help us achieve optimal oncologic outcome. I believe in working closely with patients and families to share the decision-making process.”
Education and Training
College: University of Toronto, Toronto, Canada 2005
Graduate Education: University of Toronto, Toronto, Canada 2010
Medical Education: Queen’s University, Ontario, Canada 2014
Residency: University of British Columbia, Vancouver, Canada 2019
Cho CK, Sunderland K, Pickles T, Bachand F, Chi K, Tyldesley S. A population-based study of palliative radiation therapy for bone metastases in patients dying of prostate cancer. Practical Radiation Oncology. 2019; 9(3):e274-282.
Cho CK, Sigurdson S, Davidson C, Leveridge M, Mahmud M. Testicular oligometastasis from prostate cancer: report of rare isolated recurrence after radiotherapy and intermittent androgen deprivation therapy. Canadian Urological Association Journal. 2018; 12(1): E31-33.
Karagiannis GS, Schaeffer DF, Cho CK, Musrap N, Saraon P, Grin A, Mitrovich B, Kirsch R, Riddell RH, Diamandis EP. Collective migration of cancer-associated fibroblasts is enhanced by tight junction formation. Molecular Oncology. 2014; 8(2):178-195.
Cusimano MC, Pudwell J, Roddy M, Cho CK, Smith GN. The Maternal Health Clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications. American Journal of Obstetrics &Gynecology. 2014; 210(5):438. E1-438.e9.
Cho CK, Drabovich AP, Karaggianis G, Martinez-Morillo E, Dason S, Dimitromanolakis A, Diamandis EP. Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome. Clinical Proteomics. 2013; 10(1):2.
Cho CK, Drabovich AP, Batruch I, Diamandis EP. Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay. Journal of Proteomics. 2011; 74(10):2052-9.
Cho CK, Diamandis EP. Application of proteomics to prenatal screening and diagnosis for aneuploidies. Clinical Chemistry and Labobratory Medicine. 2011; 49(1):33-41.
Cho CK, Smith CR, Diamandis EP. Amniotic fluid proteome analysis from Down Syndrome pregnancies for biomarker discovery. Journal of Proteome Research. 2010; 9(7):3574-82.
Ban K, Kim KH, Cho CK, Sauvé M, Diamandis EP, Backx PH, Drucker DJ, Husain M. GLP-1(9-36)-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor. Endocrinology. 2010; 151(4):1520-31.
Cho CK, Shan SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Molecular & Cellular Proteomics. 2007; 6(8):1406-15.